Compare · USNA vs VLON
USNA vs VLON
Side-by-side comparison of USANA Health Sciences Inc. (USNA) and Vallon Pharmaceuticals Inc. (VLON): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both USNA and VLON operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- USNA is the larger of the two at $1.86B, about 61.3x VLON ($30.3M).
- USNA has hit the wire 2 times in the past 4 weeks while VLON has been quiet.
- USNA has more recent analyst coverage (3 ratings vs 1 for VLON).
- Company
- USANA Health Sciences Inc.
- Vallon Pharmaceuticals Inc.
- Price
- $19.42+0.78%
- $12.00+2453.19%
- Market cap
- $1.86B
- $30.3M
- 1M return
- +12.65%
- -
- 1Y return
- -29.54%
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 2
- 0
- Recent ratings
- 3
- 1
USANA Health Sciences Inc.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Vallon Pharmaceuticals Inc.
Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of prescription drugs for central nervous system disorders. The company develops abuse-deterrent amphetamine immediate-release, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder and narcolepsy. It also develops ADMIR, an abuse deterrent formulation of Ritalin. Vallon Pharmaceuticals, Inc. was incorporated in 2018 and is based in Philadelphia, Pennsylvania.
Latest USNA
- USANA Schedules First Quarter 2026 Earnings Release and Conference Call
- SEC Form DEF 14A filed by USANA Health Sciences Inc.
- USANA CEO Kevin Guest Calls for Daily Health Routines on World Health Day
- Amendment: SEC Form SCHEDULE 13G/A filed by USANA Health Sciences Inc.
- Tested, Trusted, Approved: USANA CellSentials Earns ConsumerLab.com Seal of Approval for Purity and Potency
- SEC Form 4 filed by Fuller Gilbert A
- SEC Form 10-K filed by USANA Health Sciences Inc.
- Next-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer Segments
- CHIEF INFORMATION OFFICER Benedict Peter sold $88,259 worth of shares (4,553 units at $19.38), closing all direct ownership in the company (SEC Form 4)
- SEC Form 144 filed by USANA Health Sciences Inc.
Latest VLON
- SEC Form 424B3 filed by Vallon Pharmaceuticals Inc.
- Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
- SEC Form 424B4 filed by Vallon Pharmaceuticals Inc.
- SEC Form EFFECT filed by Vallon Pharmaceuticals Inc.
- SEC Form S-1/A filed by Vallon Pharmaceuticals Inc. (Amendment)
- SEC Form S-1/A filed by Vallon Pharmaceuticals Inc. (Amendment)
- SEC Form 424B3 filed by Vallon Pharmaceuticals Inc.
- Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- SEC Form 424B3 filed by Vallon Pharmaceuticals Inc.
- Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders